{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T14:12:50Z","timestamp":1788876770606,"version":"build-2803163510"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T00:00:00Z","timestamp":1782259200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:00:00Z","timestamp":1788825600000},"content-version":"vor","delay-in-days":76,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Liaoning Cancer Hospital \"Oncology+\" Project","award":["2024-ZLKF-04"],"award-info":[{"award-number":["2024-ZLKF-04"]}]},{"name":"Shenyang Breast Cancer Clinical Medical Research Center","award":["2020-48-3-1"],"award-info":[{"award-number":["2020-48-3-1"]}]},{"name":"Liaoning Provincial Key R&D Projects","award":["2024JH2\/102500058"],"award-info":[{"award-number":["2024JH2\/102500058"]}]},{"name":"Liaoning Province Key Laboratory Project of Breast Cancer Research","award":["2016-26-1"],"award-info":[{"award-number":["2016-26-1"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Cell Int"],"DOI":"10.1186\/s12935-026-04394-0","type":"journal-article","created":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T13:09:27Z","timestamp":1782306567000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The novel oleanolic acid derivative ZQL-4c modulates trastuzumab resistance in HER2+\u2009breast cancer by inhibiting SCD-mediated lipid metabolism disorders"],"prefix":"10.1186","volume":"26","author":[{"given":"Yiwen","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shisheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaorui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyu","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cui","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,24]]},"reference":[{"issue":"1","key":"4394_CR1","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/s41392-024-02108-4","volume":"10","author":"X Xiong","year":"2025","unstructured":"Xiong X, Zheng LW, Ding Y, et al. Breast cancer: pathogenesis and treatments[J]. Signal Transduct Target Ther. 2025;10(1):49. https:\/\/doi.org\/10.1038\/s41392-024-02108-4.","journal-title":"Signal Transduct Target Ther"},{"issue":"2","key":"4394_CR2","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1158\/1078-0432.CCR-25-1982","volume":"32","author":"T Adesoye","year":"2026","unstructured":"Adesoye T, Dumbrava EE, Raghav KPS, et al. Advances in Targeting HER2 across Cancer Subtypes: A Pan-Tumor Approach[J]. Clin Cancer Res. 2026;32(2):260\u201390. https:\/\/doi.org\/10.1158\/1078-0432.CCR-25-1982.","journal-title":"Clin Cancer Res"},{"issue":"4","key":"4394_CR3","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.annonc.2025.12.002","volume":"37","author":"G Gentile","year":"2026","unstructured":"Gentile G, Gerosa R, de Azambuja E, et al. 20th anniversary of adjuvant trastuzumab: reflections on a breakthrough moment[J]. Ann Oncol. 2026;37(4):470\u201380. https:\/\/doi.org\/10.1016\/j.annonc.2025.12.002.","journal-title":"Ann Oncol"},{"issue":"8","key":"4394_CR4","doi-asserted-by":"publisher","first-page":"721","DOI":"10.21037\/atm-21-1458","volume":"9","author":"X Wang","year":"2021","unstructured":"Wang X, Shao X, Huang J, et al. Exploring the concepts and practices of advanced breast cancer treatment: a narrative review[J]. Ann Transl Med. 2021;9(8):721. https:\/\/doi.org\/10.21037\/atm-21-1458.","journal-title":"Ann Transl Med"},{"key":"4394_CR5","doi-asserted-by":"publisher","first-page":"101288","DOI":"10.1016\/j.drup.2025.101288","volume":"83","author":"GY Wu","year":"2025","unstructured":"Wu GY, Xiao MZ, Hao WC, et al. Drug resistance in breast cancer: Mechanisms and strategies for management[J]. Drug Resist Updat. 2025;83:101288. https:\/\/doi.org\/10.1016\/j.drup.2025.101288.","journal-title":"Drug Resist Updat"},{"key":"4394_CR6","doi-asserted-by":"publisher","unstructured":"Yamamoto Y. Overcoming Trastuzumab-Pertuzumab Resistance and Optimizing Sequential Anti-HER2 Therapy in HER2-Positive Metastatic Breast Cancer[J]. Cancers (Basel). 2026;18(6). https:\/\/doi.org\/10.3390\/cancers18060932.","DOI":"10.3390\/cancers18060932"},{"key":"4394_CR7","doi-asserted-by":"publisher","first-page":"147431","DOI":"10.1016\/j.gene.2023.147431","volume":"871","author":"W Wu","year":"2023","unstructured":"Wu W, Sun B, He H, et al. scd knockout activates beta-oxidation of fatty acids via accumulating stearic acid (18:0) and induces anorexia in zebrafish[J]. Gene. 2023;871:147431. https:\/\/doi.org\/10.1016\/j.gene.2023.147431.","journal-title":"Gene"},{"key":"4394_CR8","doi-asserted-by":"publisher","first-page":"101374","DOI":"10.1016\/j.plipres.2025.101374","volume":"101","author":"S Ghosh","year":"2025","unstructured":"Ghosh S, Caceres R, Congrove S, et al. Stearoyl-CoA desaturase in development and disease[J]. Prog Lipid Res. 2025;101:101374. https:\/\/doi.org\/10.1016\/j.plipres.2025.101374.","journal-title":"Prog Lipid Res"},{"issue":"1","key":"4394_CR9","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s10020-023-00763-x","volume":"30","author":"J Chen","year":"2024","unstructured":"Chen J, Zhao R, Wang Y, et al. G protein-coupled estrogen receptor activates PI3K\/AKT\/mTOR signaling to suppress ferroptosis via SREBP1\/SCD1-mediated lipogenesis[J]. Mol Med. 2024;30(1):28. https:\/\/doi.org\/10.1186\/s10020-023-00763-x.","journal-title":"Mol Med"},{"key":"4394_CR10","doi-asserted-by":"publisher","unstructured":"Wang YX, Jin YY, Wang J, et al. Icaritin Derivative IC2 Induces Cytoprotective Autophagy of Breast Cancer Cells via SCD1 Inhibition[J]. Molecules. 2023;28(3). https:\/\/doi.org\/10.3390\/molecules28031109.","DOI":"10.3390\/molecules28031109"},{"issue":"3","key":"4394_CR11","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/s41419-023-05756-6","volume":"14","author":"T Wu","year":"2023","unstructured":"Wu T, Wan J, Qu X, et al. Nodal promotes colorectal cancer survival and metastasis through regulating SCD1-mediated ferroptosis resistance[J]. Cell Death Dis. 2023;14(3):229. https:\/\/doi.org\/10.1038\/s41419-023-05756-6.","journal-title":"Cell Death Dis"},{"issue":"3","key":"4394_CR12","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1038\/s41401-022-00981-9","volume":"44","author":"L Zhang","year":"2023","unstructured":"Zhang L, Li XM, Shi XH, et al. Sorafenib triggers ferroptosis via inhibition of HBXIP\/SCD axis in hepatocellular carcinoma[J]. Acta Pharmacol Sin. 2023;44(3):622\u201334. https:\/\/doi.org\/10.1038\/s41401-022-00981-9.","journal-title":"Acta Pharmacol Sin"},{"issue":"3","key":"4394_CR13","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1007\/s13402-023-00769-x","volume":"46","author":"L Castagnoli","year":"2023","unstructured":"Castagnoli L, Corso S, Franceschini A, et al. Fatty acid synthase as a new therapeutic target for HER2-positive gastric cancer[J]. Cell Oncol (Dordr). 2023;46(3):661\u201376. https:\/\/doi.org\/10.1007\/s13402-023-00769-x.","journal-title":"Cell Oncol (Dordr)"},{"issue":"9","key":"4394_CR14","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1158\/0008-5472.CAN-21-4044","volume":"82","author":"CS Kubota","year":"2022","unstructured":"Kubota CS, Espenshade PJ. Targeting Stearoyl-CoA Desaturase in Solid Tumors[J]. Cancer Res. 2022;82(9):1682\u20138. https:\/\/doi.org\/10.1158\/0008-5472.CAN-21-4044.","journal-title":"Cancer Res"},{"issue":"4","key":"4394_CR15","doi-asserted-by":"publisher","first-page":"600","DOI":"10.2174\/1389557521666210810153627","volume":"22","author":"N Gupta","year":"2022","unstructured":"Gupta N. A Review on Recent Developments in the Anticancer Potential of Oleanolic Acid and its Analogs (2017\u20132020)[J]. Mini Rev Med Chem. 2022;22(4):600\u201316. https:\/\/doi.org\/10.2174\/1389557521666210810153627.","journal-title":"Mini Rev Med Chem"},{"issue":"7","key":"4394_CR16","doi-asserted-by":"publisher","first-page":"4537","DOI":"10.1007\/s00210-024-02959-2","volume":"397","author":"Y Wang","year":"2024","unstructured":"Wang Y, Liu K. Therapeutic potential of oleanolic acid in liver diseases[J]. Naunyn Schmiedebergs Arch Pharmacol. 2024;397(7):4537\u201354. https:\/\/doi.org\/10.1007\/s00210-024-02959-2.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"7","key":"4394_CR17","doi-asserted-by":"publisher","first-page":"4425","DOI":"10.1002\/jsfa.13330","volume":"104","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Li X, Liu R, et al. Protective effect of bioactive components from Rubi fructus against oxidative damage in human ovarian granulosa cells induced by 2,2-azobis (2-methylpropionamidine) dihydrochloride[J]. J Sci Food Agric. 2024;104(7):4425\u201337. https:\/\/doi.org\/10.1002\/jsfa.13330.","journal-title":"J Sci Food Agric"},{"issue":"16","key":"4394_CR18","doi-asserted-by":"publisher","first-page":"e2300639","DOI":"10.1002\/adhm.202300639","volume":"12","author":"Y Ban","year":"2023","unstructured":"Ban Y, Chu Y, Pan F, et al. Lipid-Based Nanocarriers Enabled Oral Delivery of Oleanolic Acid Derivative DKS26 for Diabetes Management[J]. Adv Healthc Mater. 2023;12(16):e2300639. https:\/\/doi.org\/10.1002\/adhm.202300639.","journal-title":"Adv Healthc Mater"},{"issue":"2","key":"4394_CR19","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1007\/s10787-023-01419-2","volume":"32","author":"RH Mir","year":"2024","unstructured":"Mir RH, Mohi-Ud-Din R, Al-Keridis LA, et al. Phytochemical profiling, antioxidant, cytotoxic, and anti-inflammatory activities of Plectranthus rugosus extract and fractions: in vitro, in vivo, and in silico approaches[J]. Inflammopharmacology. 2024;32(2):1593\u2013606. https:\/\/doi.org\/10.1007\/s10787-023-01419-2.","journal-title":"Inflammopharmacology"},{"key":"4394_CR20","doi-asserted-by":"publisher","first-page":"115562","DOI":"10.1016\/j.ejmech.2023.115562","volume":"258","author":"L Shao","year":"2023","unstructured":"Shao L, Su Y, Zhang Y, et al. Nine-valent oleanolic acid conjugates as potent inhibitors blocking the entry of influenza A virus[J]. Eur J Med Chem. 2023;258:115562. https:\/\/doi.org\/10.1016\/j.ejmech.2023.115562.","journal-title":"Eur J Med Chem"},{"issue":"1","key":"4394_CR21","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2174\/1568026621666211105101231","volume":"22","author":"W Wang","year":"2022","unstructured":"Wang W, Li Y, Li Y, et al. Recent Progress in Oleanolic Acid: Structural Modification and Biological Activity[J]. Curr Top Med Chem. 2022;22(1):3\u201323. https:\/\/doi.org\/10.2174\/1568026621666211105101231.","journal-title":"Curr Top Med Chem"},{"issue":"6","key":"4394_CR22","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1080\/10286020.2022.2120863","volume":"25","author":"CX Gao","year":"2023","unstructured":"Gao CX, Tang CH, Wu TJ, et al. Anticancer activity of oleanolic acid and its derivatives modified at A-ring and C-28 position[J]. J Asian Nat Prod Res. 2023;25(6):581\u201394. https:\/\/doi.org\/10.1080\/10286020.2022.2120863.","journal-title":"J Asian Nat Prod Res"},{"issue":"1","key":"4394_CR23","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/S1875-5364(24)60559-5","volume":"22","author":"H Yang","year":"2024","unstructured":"Yang H, Deng M, Jia H, et al. A review of structural modification and biological activities of oleanolic acid[J]. Chin J Nat Med. 2024;22(1):15\u201330. https:\/\/doi.org\/10.1016\/S1875-5364(24)60559-5.","journal-title":"Chin J Nat Med"},{"key":"4394_CR24","doi-asserted-by":"publisher","unstructured":"Li X, Wang S, Deng N et al. N-((1-(4-Fluorophenyl)-1H-1,2,3-triazol-4-yl)methyl)-2-methylene-3-oxo-olean-12-en-28-amide Induces Apoptosis in Human Breast Cancer Cells by Stimulating Oxidative Stress and Inhibiting the Notch-Akt Signaling Pathway[J]. Oxid Med Cell Longev, 2022, 2022: 8123120. https:\/\/doi.org\/10.1155\/2022\/8123120","DOI":"10.1155\/2022\/8123120"},{"issue":"3","key":"4394_CR25","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1530\/JME-20-0075","volume":"66","author":"J Wang","year":"2021","unstructured":"Wang J, Zhang Y, Shen Q, et al. Oleanolic acid derivative HA-20 inhibits adipogenesis in a manner involving PPARgamma-FABP4\/aP2 pathway[J]. J Mol Endocrinol. 2021;66(3):245\u201358. https:\/\/doi.org\/10.1530\/JME-20-0075.","journal-title":"J Mol Endocrinol"},{"issue":"2","key":"4394_CR26","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1158\/1541-7786.MCR-21-0702","volume":"20","author":"P Fan","year":"2022","unstructured":"Fan P, Jordan VC. PERK, Beyond an Unfolded Protein Response Sensor in Estrogen-Induced Apoptosis in Endocrine-Resistant Breast Cancer[J]. Mol Cancer Res. 2022;20(2):193\u2013201. https:\/\/doi.org\/10.1158\/1541-7786.MCR-21-0702.","journal-title":"Mol Cancer Res"},{"key":"4394_CR27","doi-asserted-by":"publisher","first-page":"126466","DOI":"10.1016\/j.chemosphere.2020.126466","volume":"251","author":"X Wang","year":"2020","unstructured":"Wang X, Liu X, Chen Y, et al. Calreticulin regulated intrinsic apoptosis through mitochondria-dependent and independent pathways mediated by ER stress in arsenite exposed HT-22 cells[J]. Chemosphere. 2020;251:126466. https:\/\/doi.org\/10.1016\/j.chemosphere.2020.126466.","journal-title":"Chemosphere"},{"issue":"3","key":"4394_CR28","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1080\/15548627.2023.2259732","volume":"20","author":"Z Lin","year":"2024","unstructured":"Lin Z, Long F, Kang R, et al. The lipid basis of cell death and autophagy[J]. Autophagy. 2024;20(3):469\u201388. https:\/\/doi.org\/10.1080\/15548627.2023.2259732.","journal-title":"Autophagy"},{"issue":"33","key":"4394_CR29","doi-asserted-by":"publisher","first-page":"3744","DOI":"10.1200\/JCO.2014.55.5730","volume":"32","author":"EA Perez","year":"2014","unstructured":"Perez EA, Romond EH, Suman VJ, et al. Trastuzumab plus adjuvant chemotherapy for human epidermal growth factor receptor 2-positive breast cancer: planned joint analysis of overall survival from NSABP B-31 and NCCTG N9831[J]. J Clin Oncol. 2014;32(33):3744\u201352. https:\/\/doi.org\/10.1200\/JCO.2014.55.5730.","journal-title":"J Clin Oncol"},{"issue":"35","key":"4394_CR30","doi-asserted-by":"publisher","first-page":"3425","DOI":"10.1200\/JCO.19.00443","volume":"37","author":"S Chumsri","year":"2019","unstructured":"Chumsri S, Li Z, Serie DJ, et al. Incidence of Late Relapses in Patients With HER2-Positive Breast Cancer Receiving Adjuvant Trastuzumab: Combined Analysis of NCCTG N9831 (Alliance) and NRG Oncology\/NSABP B-31[J]. J Clin Oncol. 2019;37(35):3425\u201335. https:\/\/doi.org\/10.1200\/JCO.19.00443.","journal-title":"J Clin Oncol"},{"issue":"6","key":"4394_CR31","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1016\/S1470-2045(17)30312-1","volume":"18","author":"V Dieras","year":"2017","unstructured":"Dieras V, Miles D, Verma S, et al. Trastuzumab emtansine versus capecitabine plus lapatinib in patients with previously treated HER2-positive advanced breast cancer (EMILIA): a descriptive analysis of final overall survival results from a randomised, open-label, phase 3 trial[J]. Lancet Oncol. 2017;18(6):732\u201342. https:\/\/doi.org\/10.1016\/S1470-2045(17)30312-1.","journal-title":"Lancet Oncol"},{"issue":"2","key":"4394_CR32","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1158\/2159-8290.CD-ND2022-0020","volume":"13","author":"T-DXd Keeps Shining in Breast Cancer[J]","year":"2023","unstructured":"T-DXd Keeps Shining in Breast Cancer[J]. Cancer Discov. 2023;13(2):254. https:\/\/doi.org\/10.1158\/2159-8290.CD-ND2022-0020.","journal-title":"Cancer Discov"},{"issue":"10371","key":"4394_CR33","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/S0140-6736(22)02420-5","volume":"401","author":"SA Hurvitz","year":"2023","unstructured":"Hurvitz SA, Hegg R, Chung WP, et al. Trastuzumab deruxtecan versus trastuzumab emtansine in patients with HER2-positive metastatic breast cancer: updated results from DESTINY-Breast03, a randomised, open-label, phase 3 trial[J]. Lancet. 2023;401(10371):105\u201317. https:\/\/doi.org\/10.1016\/S0140-6736(22)02420-5.","journal-title":"Lancet"},{"key":"4394_CR34","doi-asserted-by":"publisher","unstructured":"Tapia M, Hernando C, Martinez MT, et al. Clinical Impact of New Treatment Strategies for HER2-Positive Metastatic Breast Cancer Patients with Resistance to Classical Anti-HER Therapies[J]. Cancers (Basel). 2023;15(18). https:\/\/doi.org\/10.3390\/cancers15184522.","DOI":"10.3390\/cancers15184522"},{"issue":"8","key":"4394_CR35","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1038\/s12276-023-01067-0","volume":"55","author":"BC Oh","year":"2023","unstructured":"Oh BC. Phosphoinositides and intracellular calcium signaling: novel insights into phosphoinositides and calcium coupling as negative regulators of cellular signaling[J]. Exp Mol Med. 2023;55(8):1702\u201312. https:\/\/doi.org\/10.1038\/s12276-023-01067-0.","journal-title":"Exp Mol Med"},{"issue":"8","key":"4394_CR36","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1038\/s12276-023-01077-y","volume":"55","author":"JW Kim","year":"2023","unstructured":"Kim JW, Lee JY, Oh M, et al. An integrated view of lipid metabolism in ferroptosis revisited via lipidomic analysis[J]. Exp Mol Med. 2023;55(8):1620\u201331. https:\/\/doi.org\/10.1038\/s12276-023-01077-y.","journal-title":"Exp Mol Med"},{"issue":"18","key":"4394_CR37","doi-asserted-by":"publisher","first-page":"e2309424","DOI":"10.1002\/advs.202309424","volume":"11","author":"N Duan","year":"2024","unstructured":"Duan N, Hua Y, Yan X, et al. Unveiling Alterations of Epigenetic Modifications and Chromatin Architecture Leading to Lipid Metabolic Reprogramming during the Evolutionary Trastuzumab Adaptation of HER2-Positive Breast Cancer[J]. Adv Sci (Weinh). 2024;11(18):e2309424. https:\/\/doi.org\/10.1002\/advs.202309424.","journal-title":"Adv Sci (Weinh)"},{"issue":"6","key":"4394_CR38","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1038\/s41416-023-02559-6","volume":"130","author":"J Wang","year":"2024","unstructured":"Wang J, Sun N, Kunzke T, et al. Metabolic heterogeneity affects trastuzumab response and survival in HER2-positive advanced gastric cancer[J]. Br J Cancer. 2024;130(6):1036\u201345. https:\/\/doi.org\/10.1038\/s41416-023-02559-6.","journal-title":"Br J Cancer"},{"issue":"1","key":"4394_CR39","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s10555-024-10170-1","volume":"43","author":"R Vishwa","year":"2024","unstructured":"Vishwa R, BharathwajChetty B, Girisa S, et al. Lipid metabolism and its implications in tumor cell plasticity and drug resistance: what we learned thus far?[J]. Cancer Metastasis Rev. 2024;43(1):293\u2013319. https:\/\/doi.org\/10.1007\/s10555-024-10170-1.","journal-title":"Cancer Metastasis Rev"},{"issue":"41","key":"4394_CR40","doi-asserted-by":"publisher","first-page":"e2203480119","DOI":"10.1073\/pnas.2203480119","volume":"119","author":"G Zhao","year":"2022","unstructured":"Zhao G, Tan Y, Cardenas H, et al. Ovarian cancer cell fate regulation by the dynamics between saturated and unsaturated fatty acids[J]. Proc Natl Acad Sci U S A. 2022;119(41):e2203480119. https:\/\/doi.org\/10.1073\/pnas.2203480119.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"4394_CR41","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1186\/s12935-022-02621-y","volume":"22","author":"C Yang","year":"2022","unstructured":"Yang C, Jin YY, Mei J, et al. Identification of icaritin derivative IC2 as an SCD-1 inhibitor with anti-breast cancer properties through induction of cell apoptosis[J]. Cancer Cell Int. 2022;22(1):202. https:\/\/doi.org\/10.1186\/s12935-022-02621-y.","journal-title":"Cancer Cell Int"},{"issue":"1","key":"4394_CR42","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/s41420-025-02862-6","volume":"11","author":"H Chai","year":"2025","unstructured":"Chai H, Hu Q, Yao S, et al. Endoplasmic reticulum stress-mediated programmed cell death in the tumor microenvironment[J]. Cell Death Discov. 2025;11(1):559. https:\/\/doi.org\/10.1038\/s41420-025-02862-6.","journal-title":"Cell Death Discov"}],"container-title":["Cancer Cell International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12935-026-04394-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-026-04394-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-026-04394-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T14:04:18Z","timestamp":1788876258000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12935-026-04394-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,24]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4394"],"URL":"https:\/\/doi.org\/10.1186\/s12935-026-04394-0","relation":{},"ISSN":["1475-2867"],"issn-type":[{"value":"1475-2867","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,24]]},"assertion":[{"value":"2 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All animal experiments were approved by the Welfare Ethics Committee of the Department of Laboratory Animals, China Medical University (approval ID: CMU2022040).","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors give consent for the publication of the manuscript in Cancer Cell International.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"304"}}